Delivery Order SPE2DB22D1106-SPE2DB24FEEU8
- Not listed
- This federal contract award is for the delivery of PATADAY TWICE DAILY 0.1% DROPS 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $1,072.08 and is a Firm Fixed Price Delivery Order with a completion date of May 29, 2024. This appears to be a standalone contract award and...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,736.96 delivery order contract is for the supply of Pataday 0.1% eye drops. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
- The Defense Logistics Agency Troop Support Medical awarded a $11,070 delivery order to DMS Pharmaceutical Group Inc. to supply 4561917690 PATADAY TWICE DAILY 0.1% DROPS 5ML. The firm fixed price order is being fulfilled under a larger Prime Vendor contract vehicle and has a period of performance from August 14-15, 2023. As the DLA is responsible for procuring medical supplies and equipment for all branches of the U.S. military, this order will deliver an ophthalmic drug to support the healthcare...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,382.67 firm fixed-price delivery order is for the supply of OLOPATADINE 0.1% OS 1S, a prescription eye drop medication. The contract has an ultimate completion date of April 18, 2025 and was awarded on March 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,801.16 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops (5ml) on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through full and open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,380.55 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops (5 mL units). This firm fixed price, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract represents a non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5 mL units) with a ceiling value of $1,148.94. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Olopatadine HCL 0.1% Eye Drops in 5ML units, valued at $1,763.56. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,046.81 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml quantities. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in Conshohocken, PA....
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xdemvy 0.25% drop in a 10ml formulation. This firm fixed price delivery order, which is not associated with a set-aside program, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a child contract under AmerisourceBergen's larger indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEEU8Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,119.85, is for the supply of PATADAY TWICE DAILY 0.1% DROPS 5ML, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense, through various contract vehicles. This includes an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract awarded in this case does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/26/24 |